

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.83415060 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.83415060 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 4.83415060 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.83415060 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.83415060 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.83415060 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.31503277 |
| 8 | response to peptidoglycan (GO:0032494) | 4.28237016 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.25561095 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 4.13706104 |
| 11 | detection of other organism (GO:0098543) | 4.10818350 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.08716095 |
| 13 | detection of bacterium (GO:0016045) | 4.05152286 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.04981686 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.03124075 |
| 16 | negative regulation of cell killing (GO:0031342) | 4.03124075 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 3.90540997 |
| 18 | hepatocyte apoptotic process (GO:0097284) | 3.87970109 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.71889386 |
| 20 | germ cell migration (GO:0008354) | 3.70211339 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 3.64124158 |
| 22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.56921694 |
| 23 | germinal center formation (GO:0002467) | 3.51800682 |
| 24 | defense response to protozoan (GO:0042832) | 3.48230737 |
| 25 | regulation of antigen processing and presentation (GO:0002577) | 3.40512926 |
| 26 | B cell homeostasis (GO:0001782) | 3.37124018 |
| 27 | regulation of mast cell degranulation (GO:0043304) | 3.36504104 |
| 28 | serine transport (GO:0032329) | 3.35897436 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.33118215 |
| 30 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.33022358 |
| 31 | V(D)J recombination (GO:0033151) | 3.31878441 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.31023680 |
| 33 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29948307 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.29201032 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28613412 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28613412 |
| 37 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27959662 |
| 38 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.26947531 |
| 39 | regulation of leukocyte degranulation (GO:0043300) | 3.24594441 |
| 40 | natural killer cell differentiation (GO:0001779) | 3.23845698 |
| 41 | response to host immune response (GO:0052572) | 3.23506550 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23506550 |
| 43 | growth hormone receptor signaling pathway (GO:0060396) | 3.23456272 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.23395463 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.22898272 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.21641734 |
| 47 | response to protozoan (GO:0001562) | 3.21168825 |
| 48 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.16215159 |
| 49 | response to host (GO:0075136) | 3.15681775 |
| 50 | response to host defenses (GO:0052200) | 3.15681775 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.15681775 |
| 52 | cellular extravasation (GO:0045123) | 3.14816087 |
| 53 | B cell receptor signaling pathway (GO:0050853) | 3.14512261 |
| 54 | L-serine transport (GO:0015825) | 3.14233147 |
| 55 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.13705403 |
| 56 | response to type I interferon (GO:0034340) | 3.11498484 |
| 57 | cellular response to type I interferon (GO:0071357) | 3.11482465 |
| 58 | type I interferon signaling pathway (GO:0060337) | 3.11482465 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07822670 |
| 60 | B cell mediated immunity (GO:0019724) | 3.07499035 |
| 61 | cellular hyperosmotic response (GO:0071474) | 3.07227230 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07044885 |
| 63 | T-helper 1 type immune response (GO:0042088) | 3.04324276 |
| 64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02316198 |
| 65 | detection of biotic stimulus (GO:0009595) | 3.01783844 |
| 66 | positive regulation of mast cell activation (GO:0033005) | 3.01477880 |
| 67 | positive regulation of type 2 immune response (GO:0002830) | 3.01292892 |
| 68 | regulation of extracellular matrix disassembly (GO:0010715) | 2.96687993 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 2.96336622 |
| 70 | negative thymic T cell selection (GO:0045060) | 2.95182453 |
| 71 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.94540885 |
| 72 | T cell selection (GO:0045058) | 2.93096294 |
| 73 | detection of molecule of bacterial origin (GO:0032490) | 2.91609224 |
| 74 | positive regulation of histone deacetylation (GO:0031065) | 2.91436933 |
| 75 | thymic T cell selection (GO:0045061) | 2.90433170 |
| 76 | regulation of interferon-alpha production (GO:0032647) | 2.88805923 |
| 77 | myeloid dendritic cell differentiation (GO:0043011) | 2.87618890 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 2.87374990 |
| 79 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.84789367 |
| 80 | positive regulation of mast cell degranulation (GO:0043306) | 2.83560760 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83560760 |
| 82 | macrophage activation involved in immune response (GO:0002281) | 2.83122620 |
| 83 | regulation of histone H3-K9 methylation (GO:0051570) | 2.82215007 |
| 84 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.80378000 |
| 85 | response to laminar fluid shear stress (GO:0034616) | 2.79378216 |
| 86 | myeloid dendritic cell activation (GO:0001773) | 2.79150834 |
| 87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78906914 |
| 88 | cellular response to growth hormone stimulus (GO:0071378) | 2.78820612 |
| 89 | NIK/NF-kappaB signaling (GO:0038061) | 2.78816296 |
| 90 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.78390655 |
| 91 | N-acetylneuraminate metabolic process (GO:0006054) | 2.74973801 |
| 92 | endothelial tube morphogenesis (GO:0061154) | 2.72902085 |
| 93 | morphogenesis of an endothelium (GO:0003159) | 2.72902085 |
| 94 | regulation of B cell differentiation (GO:0045577) | 2.72862022 |
| 95 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.71731719 |
| 96 | T cell migration (GO:0072678) | 2.69841719 |
| 97 | macrophage activation (GO:0042116) | 2.69134588 |
| 98 | regulation of mast cell activation (GO:0033003) | 2.68841483 |
| 99 | regulation of hippo signaling (GO:0035330) | 2.68178468 |
| 100 | neutrophil activation (GO:0042119) | 2.67175496 |
| 101 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.65819599 |
| 102 | histone H3-K36 demethylation (GO:0070544) | 2.65190946 |
| 103 | positive regulation by host of viral transcription (GO:0043923) | 2.65103980 |
| 104 | surfactant homeostasis (GO:0043129) | 2.64804184 |
| 105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.64702211 |
| 106 | negative T cell selection (GO:0043383) | 2.64108899 |
| 107 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.63943761 |
| 108 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.63943761 |
| 109 | neutrophil activation involved in immune response (GO:0002283) | 2.63149047 |
| 110 | hippo signaling (GO:0035329) | 2.63031271 |
| 111 | T cell costimulation (GO:0031295) | 2.63008645 |
| 112 | negative regulation of granulocyte differentiation (GO:0030853) | 2.61836332 |
| 113 | positive regulation of Rap GTPase activity (GO:0032854) | 2.61051566 |
| 114 | positive regulation of B cell proliferation (GO:0030890) | 2.60713905 |
| 115 | positive regulation of B cell activation (GO:0050871) | 2.60651963 |
| 116 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60399226 |
| 117 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.59860033 |
| 118 | lymphocyte costimulation (GO:0031294) | 2.58419746 |
| 119 | granulocyte activation (GO:0036230) | 2.56685796 |
| 120 | histone H3-K9 demethylation (GO:0033169) | 2.47412694 |
| 121 | negative regulation of histone methylation (GO:0031061) | 2.47396925 |
| 122 | lymph vessel development (GO:0001945) | 2.44808527 |
| 123 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.44558738 |
| 124 | establishment of epithelial cell polarity (GO:0090162) | 2.43299633 |
| 125 | cellular response to osmotic stress (GO:0071470) | 2.43031212 |
| 126 | histone lysine demethylation (GO:0070076) | 2.40141245 |
| 127 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39857940 |
| 128 | chromatin assembly (GO:0031497) | 2.34107713 |
| 129 | regulation of superoxide anion generation (GO:0032928) | 2.33158830 |
| 130 | myelin maintenance (GO:0043217) | 2.32093288 |
| 131 | establishment of apical/basal cell polarity (GO:0035089) | 2.32060216 |
| 132 | negative regulation of B cell proliferation (GO:0030889) | 2.28823930 |
| 133 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.27929502 |
| 134 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.27825983 |
| 135 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.26588344 |
| 136 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.25504083 |
| 137 | receptor catabolic process (GO:0032801) | 2.25429973 |
| 138 | cortical actin cytoskeleton organization (GO:0030866) | 2.25374319 |
| 139 | positive regulation of leukocyte degranulation (GO:0043302) | 2.25099543 |
| 140 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.24766996 |
| 141 | response to muramyl dipeptide (GO:0032495) | 2.24581589 |
| 142 | maternal placenta development (GO:0001893) | 2.22477900 |
| 143 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.21448991 |
| 144 | histone demethylation (GO:0016577) | 2.19082049 |
| 145 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.18187934 |
| 146 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.17732354 |
| 147 | lung lobe morphogenesis (GO:0060463) | 2.16558616 |
| 148 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.14417466 |
| 149 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.13447397 |
| 150 | response to fluid shear stress (GO:0034405) | 2.12547774 |
| 151 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.11521893 |
| 152 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.10258586 |
| 153 | Peyers patch development (GO:0048541) | 2.10258586 |
| 154 | renal system development (GO:0072001) | 2.09267871 |
| 155 | cellular response to zinc ion (GO:0071294) | 2.07374452 |
| 156 | negative regulation of bone resorption (GO:0045779) | 2.06962347 |
| 157 | ruffle organization (GO:0031529) | 2.06687150 |
| 158 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.05265706 |
| 159 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.05136992 |
| 160 | cell proliferation involved in metanephros development (GO:0072203) | 2.05032565 |
| 161 | lens fiber cell development (GO:0070307) | 2.03873515 |
| 162 | embryonic foregut morphogenesis (GO:0048617) | 2.02335915 |
| 163 | patterning of blood vessels (GO:0001569) | 2.02099222 |
| 164 | regulation of sister chromatid cohesion (GO:0007063) | 2.02066654 |
| 165 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.00628404 |
| 166 | regulation of RNA export from nucleus (GO:0046831) | 2.00443660 |
| 167 | apoptotic cell clearance (GO:0043277) | 2.00177099 |
| 168 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.00172207 |
| 169 | corticosteroid receptor signaling pathway (GO:0031958) | 1.99980301 |
| 170 | entry into host (GO:0044409) | 1.99935647 |
| 171 | entry into other organism involved in symbiotic interaction (GO:0051828) | 1.99935647 |
| 172 | movement in host environment (GO:0052126) | 1.99935647 |
| 173 | entry into host cell (GO:0030260) | 1.99935647 |
| 174 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 1.99935647 |
| 175 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 1.99935647 |
| 176 | negative regulation of fatty acid transport (GO:2000192) | 1.99684766 |
| 177 | regulation of toll-like receptor signaling pathway (GO:0034121) | 1.99207109 |
| 178 | regulation of T cell tolerance induction (GO:0002664) | 1.98415845 |
| 179 | mannose metabolic process (GO:0006013) | 1.97478211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.52474600 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.05783360 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.68157734 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.39262720 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18627367 |
| 6 | * MYC_22102868_ChIP-Seq_BL_Human | 3.16881016 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.15601396 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.86255825 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.83869879 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66205735 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.52563821 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37292048 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20364390 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.19109902 |
| 15 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.09022039 |
| 16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.05512821 |
| 17 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.02199098 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.00215506 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.93298717 |
| 20 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.91415369 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90618484 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89971386 |
| 23 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89617783 |
| 24 | * MAF_26560356_Chip-Seq_TH1_Human | 1.89211974 |
| 25 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.85581496 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85071211 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.84491049 |
| 28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.82010243 |
| 29 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.79144855 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79135859 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75660517 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75247947 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.74212415 |
| 34 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71408889 |
| 35 | * MAF_26560356_Chip-Seq_TH2_Human | 1.70111391 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69711326 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69706437 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67609649 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66191632 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66086863 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64527159 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63872724 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62691371 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60733201 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58322489 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58167419 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56174870 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54477046 |
| 49 | * MYB_26560356_Chip-Seq_TH2_Human | 1.52783900 |
| 50 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.52362657 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51254769 |
| 52 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50410737 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48721741 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44221338 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42505623 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42155741 |
| 57 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41412322 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39133454 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38195550 |
| 60 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.38169265 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38167217 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.36902860 |
| 63 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36892296 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.36274497 |
| 65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34735220 |
| 66 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33328488 |
| 67 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.28617666 |
| 68 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.28397256 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27713861 |
| 70 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27250325 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26794613 |
| 72 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25872138 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24595858 |
| 74 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24184992 |
| 75 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23186191 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21317426 |
| 77 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21014319 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20364644 |
| 79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.19866648 |
| 80 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19644039 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19404301 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19099057 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18875694 |
| 84 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.18333970 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.18281500 |
| 86 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18249689 |
| 87 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16254996 |
| 88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15787748 |
| 89 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15577820 |
| 90 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.15460940 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14983981 |
| 92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14846445 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14625213 |
| 94 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.14124671 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.14004587 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12930841 |
| 97 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12806304 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11796584 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11691847 |
| 100 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11573451 |
| 101 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10778298 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10710153 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10170462 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10065167 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08962998 |
| 106 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.08712540 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08697778 |
| 108 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.08375620 |
| 109 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07879227 |
| 110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07674972 |
| 111 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06020669 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05769726 |
| 113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04818675 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04611265 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03971963 |
| 116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03260772 |
| 117 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.00384244 |
| 118 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99979416 |
| 119 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99109501 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98101422 |
| 121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97850645 |
| 122 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97674108 |
| 123 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97573625 |
| 124 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.95905020 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95667519 |
| 126 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.95352907 |
| 127 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.94850619 |
| 128 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94566218 |
| 129 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94255924 |
| 130 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93872389 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92450204 |
| 132 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91133560 |
| 133 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91106492 |
| 134 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90835280 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90059810 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89767231 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86815551 |
| 138 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86491803 |
| 139 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82629048 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81841681 |
| 141 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80549379 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79597041 |
| 143 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79584711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 3.06561776 |
| 2 | MP0002166_altered_tumor_susceptibility | 2.61047957 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 2.59837831 |
| 4 | MP0002254_reproductive_system_inflammat | 2.55904213 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.55354615 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.44230854 |
| 7 | MP0003724_increased_susceptibility_to | 2.36803235 |
| 8 | MP0006054_spinal_hemorrhage | 2.22744633 |
| 9 | MP0009785_altered_susceptibility_to | 2.20706630 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.16994822 |
| 11 | MP0005076_abnormal_cell_differentiation | 2.13476607 |
| 12 | MP0009278_abnormal_bone_marrow | 2.10901322 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.08270737 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.05207122 |
| 15 | MP0000685_abnormal_immune_system | 1.99779257 |
| 16 | MP0003183_abnormal_peptide_metabolism | 1.96091365 |
| 17 | MP0005451_abnormal_body_composition | 1.91635640 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 1.88727722 |
| 19 | MP0003303_peritoneal_inflammation | 1.87232785 |
| 20 | MP0001879_abnormal_lymphatic_vessel | 1.85619129 |
| 21 | MP0002006_tumorigenesis | 1.82043111 |
| 22 | * MP0001800_abnormal_humoral_immune | 1.73592160 |
| 23 | MP0004510_myositis | 1.71753271 |
| 24 | MP0001790_abnormal_immune_system | 1.71272825 |
| 25 | MP0005387_immune_system_phenotype | 1.71272825 |
| 26 | MP0008260_abnormal_autophagy | 1.69777574 |
| 27 | MP0001849_ear_inflammation | 1.65866870 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.63108302 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.59526996 |
| 30 | MP0002009_preneoplasia | 1.54556772 |
| 31 | * MP0002452_abnormal_antigen_presenting | 1.53580515 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.52256222 |
| 33 | MP0003828_pulmonary_edema | 1.51239896 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.50041168 |
| 35 | MP0002998_abnormal_bone_remodeling | 1.49245502 |
| 36 | MP0009840_abnormal_foam_cell | 1.49012571 |
| 37 | MP0001853_heart_inflammation | 1.48458494 |
| 38 | MP0004947_skin_inflammation | 1.47122836 |
| 39 | MP0000537_abnormal_urethra_morphology | 1.37251604 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.31743155 |
| 41 | MP0008469_abnormal_protein_level | 1.31167467 |
| 42 | MP0010678_abnormal_skin_adnexa | 1.29680422 |
| 43 | MP0000767_abnormal_smooth_muscle | 1.28468337 |
| 44 | MP0001915_intracranial_hemorrhage | 1.25804131 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 1.25564160 |
| 46 | MP0009053_abnormal_anal_canal | 1.24794036 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.21666481 |
| 48 | MP0005671_abnormal_response_to | 1.20463182 |
| 49 | * MP0002420_abnormal_adaptive_immunity | 1.19181874 |
| 50 | * MP0001819_abnormal_immune_cell | 1.19091843 |
| 51 | MP0000858_altered_metastatic_potential | 1.18111225 |
| 52 | MP0000733_abnormal_muscle_development | 1.18038121 |
| 53 | MP0001958_emphysema | 1.17111403 |
| 54 | MP0003866_abnormal_defecation | 1.16711987 |
| 55 | * MP0002723_abnormal_immune_serum | 1.16149952 |
| 56 | MP0003252_abnormal_bile_duct | 1.16039947 |
| 57 | MP0003436_decreased_susceptibility_to | 1.15601941 |
| 58 | * MP0002398_abnormal_bone_marrow | 1.14465055 |
| 59 | MP0003091_abnormal_cell_migration | 1.12964398 |
| 60 | MP0010368_abnormal_lymphatic_system | 1.12646518 |
| 61 | * MP0000716_abnormal_immune_system | 1.12203090 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.10271466 |
| 63 | MP0001873_stomach_inflammation | 1.07801052 |
| 64 | * MP0000689_abnormal_spleen_morphology | 1.07767442 |
| 65 | MP0002405_respiratory_system_inflammati | 1.07229297 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.06058794 |
| 67 | MP0004264_abnormal_extraembryonic_tissu | 1.04836873 |
| 68 | MP0001663_abnormal_digestive_system | 1.03944292 |
| 69 | MP0009764_decreased_sensitivity_to | 1.03245658 |
| 70 | MP0000490_abnormal_crypts_of | 1.02359742 |
| 71 | MP0002092_abnormal_eye_morphology | 1.02263982 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.02257852 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 1.01430934 |
| 74 | MP0005310_abnormal_salivary_gland | 1.01393494 |
| 75 | * MP0002722_abnormal_immune_system | 1.00460716 |
| 76 | MP0004381_abnormal_hair_follicle | 0.98328408 |
| 77 | MP0002925_abnormal_cardiovascular_devel | 0.95180487 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.94746987 |
| 79 | MP0003075_altered_response_to | 0.94613572 |
| 80 | MP0005023_abnormal_wound_healing | 0.94417512 |
| 81 | * MP0002429_abnormal_blood_cell | 0.93226623 |
| 82 | MP0003115_abnormal_respiratory_system | 0.93082840 |
| 83 | MP0004197_abnormal_fetal_growth/weight/ | 0.92883846 |
| 84 | MP0006082_CNS_inflammation | 0.92568617 |
| 85 | MP0000604_amyloidosis | 0.90672571 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.90511490 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.90511490 |
| 88 | MP0002419_abnormal_innate_immunity | 0.90251215 |
| 89 | MP0002928_abnormal_bile_duct | 0.90245091 |
| 90 | MP0001851_eye_inflammation | 0.89192690 |
| 91 | MP0003279_aneurysm | 0.88242824 |
| 92 | MP0000609_abnormal_liver_physiology | 0.86450390 |
| 93 | MP0004272_abnormal_basement_membrane | 0.85764100 |
| 94 | MP0001346_abnormal_lacrimal_gland | 0.85154664 |
| 95 | MP0000462_abnormal_digestive_system | 0.84791006 |
| 96 | MP0005025_abnormal_response_to | 0.83866233 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.82585609 |
| 98 | MP0002086_abnormal_extraembryonic_tissu | 0.82450038 |
| 99 | MP0008004_abnormal_stomach_pH | 0.82077733 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.81990887 |
| 101 | MP0003448_altered_tumor_morphology | 0.81836398 |
| 102 | MP0010030_abnormal_orbit_morphology | 0.81346170 |
| 103 | MP0000383_abnormal_hair_follicle | 0.81277102 |
| 104 | MP0002060_abnormal_skin_morphology | 0.81183164 |
| 105 | MP0002933_joint_inflammation | 0.80921865 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.80763778 |
| 107 | MP0010307_abnormal_tumor_latency | 0.80161506 |
| 108 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79212501 |
| 109 | MP0003763_abnormal_thymus_physiology | 0.78843702 |
| 110 | MP0005166_decreased_susceptibility_to | 0.76705166 |
| 111 | MP0002088_abnormal_embryonic_growth/wei | 0.76007343 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.75899422 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.75576159 |
| 114 | MP0000249_abnormal_blood_vessel | 0.75347639 |
| 115 | MP0003984_embryonic_growth_retardation | 0.75145753 |
| 116 | MP0002132_abnormal_respiratory_system | 0.74639804 |
| 117 | MP0001614_abnormal_blood_vessel | 0.74183557 |
| 118 | MP0005075_abnormal_melanosome_morpholog | 0.73877430 |
| 119 | MP0002098_abnormal_vibrissa_morphology | 0.73703717 |
| 120 | MP0000350_abnormal_cell_proliferation | 0.73281204 |
| 121 | MP0002148_abnormal_hypersensitivity_rea | 0.72941228 |
| 122 | MP0000627_abnormal_mammary_gland | 0.72805881 |
| 123 | MP0002139_abnormal_hepatobiliary_system | 0.71900439 |
| 124 | MP0000465_gastrointestinal_hemorrhage | 0.71811607 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.71128985 |
| 126 | MP0001175_abnormal_lung_morphology | 0.70823354 |
| 127 | MP0005390_skeleton_phenotype | 0.70746723 |
| 128 | MP0009115_abnormal_fat_cell | 0.70379172 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.69132387 |
| 130 | MP0003656_abnormal_erythrocyte_physiolo | 0.68670705 |
| 131 | MP0000343_altered_response_to | 0.67328135 |
| 132 | MP0005409_darkened_coat_color | 0.65629576 |
| 133 | MP0001348_abnormal_lacrimal_gland | 0.62849037 |
| 134 | MP0003795_abnormal_bone_structure | 0.61843619 |
| 135 | MP0008057_abnormal_DNA_replication | 0.61811062 |
| 136 | MP0000371_diluted_coat_color | 0.61432871 |
| 137 | MP0004883_abnormal_blood_vessel | 0.60389585 |
| 138 | MP0009763_increased_sensitivity_to | 0.58409693 |
| 139 | MP0003690_abnormal_glial_cell | 0.58319336 |
| 140 | MP0000015_abnormal_ear_pigmentation | 0.57805437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.32336953 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.28867745 |
| 3 | Hematochezia (HP:0002573) | 3.93191876 |
| 4 | Mediastinal lymphadenopathy (HP:0100721) | 3.78366192 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.78227539 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.78227539 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.78227539 |
| 8 | Abnormality of B cell number (HP:0010975) | 3.48534997 |
| 9 | B lymphocytopenia (HP:0010976) | 3.48534997 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46659974 |
| 11 | Thyroiditis (HP:0100646) | 3.45875518 |
| 12 | Papilloma (HP:0012740) | 3.38962335 |
| 13 | Verrucae (HP:0200043) | 3.38962335 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.35543887 |
| 15 | Recurrent viral infections (HP:0004429) | 3.33267959 |
| 16 | Vasculitis (HP:0002633) | 3.32649963 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30853393 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30853393 |
| 19 | Colitis (HP:0002583) | 3.30216594 |
| 20 | Cellulitis (HP:0100658) | 3.29179239 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28325321 |
| 22 | Agammaglobulinemia (HP:0004432) | 3.23120426 |
| 23 | Recurrent skin infections (HP:0001581) | 3.22538051 |
| 24 | Ulnar bowing (HP:0003031) | 3.19258647 |
| 25 | Myositis (HP:0100614) | 3.16819037 |
| 26 | Orchitis (HP:0100796) | 3.14858536 |
| 27 | Cerebral aneurysm (HP:0004944) | 3.14487155 |
| 28 | Dysostosis multiplex (HP:0000943) | 3.11223893 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.97918577 |
| 30 | Optic neuritis (HP:0100653) | 2.97918577 |
| 31 | Recurrent sinusitis (HP:0011108) | 2.93926771 |
| 32 | Increased IgE level (HP:0003212) | 2.88325378 |
| 33 | Obstructive lung disease (HP:0006536) | 2.86987678 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.86987678 |
| 35 | Restrictive lung disease (HP:0002091) | 2.83761922 |
| 36 | Abnormality of the fingertips (HP:0001211) | 2.82528239 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.82424520 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.81657232 |
| 39 | Eosinophilia (HP:0001880) | 2.81297079 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.79592901 |
| 41 | T lymphocytopenia (HP:0005403) | 2.72882662 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.72534144 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.72087073 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.71399934 |
| 45 | Aortic aneurysm (HP:0004942) | 2.71283677 |
| 46 | Lymphopenia (HP:0001888) | 2.68104522 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.66977071 |
| 48 | Esophageal varix (HP:0002040) | 2.66912940 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.66840659 |
| 50 | Thoracic kyphosis (HP:0002942) | 2.62625648 |
| 51 | Vertebral arch anomaly (HP:0008438) | 2.60273256 |
| 52 | Loss of speech (HP:0002371) | 2.59776123 |
| 53 | Encephalitis (HP:0002383) | 2.58733919 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.55584061 |
| 55 | Hypoplasia of the thymus (HP:0000778) | 2.51612871 |
| 56 | Mitral valve prolapse (HP:0001634) | 2.49790587 |
| 57 | Mitral stenosis (HP:0001718) | 2.47292694 |
| 58 | Gingivitis (HP:0000230) | 2.45904483 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.45318614 |
| 60 | Stomatitis (HP:0010280) | 2.44966180 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44524330 |
| 62 | Small epiphyses (HP:0010585) | 2.44130903 |
| 63 | Recurrent pneumonia (HP:0006532) | 2.44030042 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.43531357 |
| 65 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.43087603 |
| 66 | Short 4th metacarpal (HP:0010044) | 2.43087603 |
| 67 | Severe combined immunodeficiency (HP:0004430) | 2.39371395 |
| 68 | IgM deficiency (HP:0002850) | 2.34433090 |
| 69 | Arterial tortuosity (HP:0005116) | 2.33056610 |
| 70 | Subacute progressive viral hepatitis (HP:0006572) | 2.32389384 |
| 71 | Urticaria (HP:0001025) | 2.31204146 |
| 72 | Chest pain (HP:0100749) | 2.30041964 |
| 73 | Hemoptysis (HP:0002105) | 2.29525094 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.29267811 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27917919 |
| 76 | Recurrent lower respiratory tract infections (HP:0002783) | 2.27543589 |
| 77 | Chronic diarrhea (HP:0002028) | 2.27058286 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25905221 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25905221 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25905221 |
| 81 | Mucopolysacchariduria (HP:0008155) | 2.25706915 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25706915 |
| 83 | Rectal prolapse (HP:0002035) | 2.25247003 |
| 84 | Osteomyelitis (HP:0002754) | 2.22190115 |
| 85 | Malnutrition (HP:0004395) | 2.19423527 |
| 86 | Disproportionate tall stature (HP:0001519) | 2.18778045 |
| 87 | Hyperacusis (HP:0010780) | 2.18730550 |
| 88 | Myocardial infarction (HP:0001658) | 2.17707755 |
| 89 | Abnormality of the intervertebral disk (HP:0005108) | 2.16448057 |
| 90 | Asymmetry of the thorax (HP:0001555) | 2.14965570 |
| 91 | Abnormality of the thoracic spine (HP:0100711) | 2.13261917 |
| 92 | Disinhibition (HP:0000734) | 2.10881901 |
| 93 | Bicuspid aortic valve (HP:0001647) | 2.09768474 |
| 94 | Granulocytopenia (HP:0001913) | 2.08354114 |
| 95 | Purpura (HP:0000979) | 2.08315012 |
| 96 | Epistaxis (HP:0000421) | 2.07865199 |
| 97 | Hemorrhage of the eye (HP:0011885) | 2.04688742 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04410538 |
| 99 | Aortic dissection (HP:0002647) | 2.03962481 |
| 100 | Arterial thrombosis (HP:0004420) | 2.03370756 |
| 101 | Pulmonary embolism (HP:0002204) | 2.03196197 |
| 102 | Abnormality of the 4th metacarpal (HP:0010012) | 2.02880066 |
| 103 | Abnormality of the lumbar spine (HP:0100712) | 2.02254796 |
| 104 | Spondylolisthesis (HP:0003302) | 2.01860239 |
| 105 | Prolonged bleeding time (HP:0003010) | 2.01840861 |
| 106 | Vascular tortuosity (HP:0004948) | 2.01757797 |
| 107 | Osteolytic defects of the hand bones (HP:0009699) | 2.00427272 |
| 108 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00427272 |
| 109 | Autoimmune thrombocytopenia (HP:0001973) | 1.98290160 |
| 110 | Keratoconjunctivitis sicca (HP:0001097) | 1.97515064 |
| 111 | Chronic otitis media (HP:0000389) | 1.96834451 |
| 112 | Pustule (HP:0200039) | 1.94480423 |
| 113 | Meningitis (HP:0001287) | 1.93118712 |
| 114 | Camptodactyly of toe (HP:0001836) | 1.92610854 |
| 115 | Abnormality of eosinophils (HP:0001879) | 1.92551573 |
| 116 | Amyloidosis (HP:0011034) | 1.92186290 |
| 117 | Abnormality of the pleura (HP:0002103) | 1.91802539 |
| 118 | Deep venous thrombosis (HP:0002625) | 1.91051741 |
| 119 | Hypoproteinemia (HP:0003075) | 1.90613395 |
| 120 | Bowing of the arm (HP:0006488) | 1.90523437 |
| 121 | Bowed forearm bones (HP:0003956) | 1.90523437 |
| 122 | Recurrent bronchitis (HP:0002837) | 1.88706745 |
| 123 | Abnormality of T cells (HP:0002843) | 1.88531744 |
| 124 | Cortical dysplasia (HP:0002539) | 1.88493271 |
| 125 | Abnormality of the peritoneum (HP:0002585) | 1.87664438 |
| 126 | Micronodular cirrhosis (HP:0001413) | 1.86654842 |
| 127 | Abnormality of T cell physiology (HP:0011840) | 1.86578287 |
| 128 | Complement deficiency (HP:0004431) | 1.86293236 |
| 129 | Systemic lupus erythematosus (HP:0002725) | 1.85129085 |
| 130 | Gingival bleeding (HP:0000225) | 1.85054465 |
| 131 | Visceral angiomatosis (HP:0100761) | 1.83911801 |
| 132 | Shallow orbits (HP:0000586) | 1.83694359 |
| 133 | Arthralgia (HP:0002829) | 1.83410042 |
| 134 | Lymphangioma (HP:0100764) | 1.82964586 |
| 135 | Hemangiomatosis (HP:0007461) | 1.82864372 |
| 136 | Neuronal loss in central nervous system (HP:0002529) | 1.82800330 |
| 137 | Viral hepatitis (HP:0006562) | 1.81819863 |
| 138 | Aneurysm (HP:0002617) | 1.81667719 |
| 139 | Polygenic inheritance (HP:0010982) | 1.80759562 |
| 140 | Premature loss of primary teeth (HP:0006323) | 1.80256251 |
| 141 | Recurrent bacterial skin infections (HP:0005406) | 1.80159230 |
| 142 | Polycythemia (HP:0001901) | 1.79709487 |
| 143 | Acrocyanosis (HP:0001063) | 1.79179191 |
| 144 | Pseudobulbar signs (HP:0002200) | 1.77836806 |
| 145 | Sepsis (HP:0100806) | 1.77729007 |
| 146 | Hallux valgus (HP:0001822) | 1.77287528 |
| 147 | Deviation of the hallux (HP:0010051) | 1.74886209 |
| 148 | Leukocytosis (HP:0001974) | 1.73020692 |
| 149 | Fatigue (HP:0012378) | 1.72774341 |
| 150 | Macroorchidism (HP:0000053) | 1.72742646 |
| 151 | Arnold-Chiari malformation (HP:0002308) | 1.71075161 |
| 152 | Broad metatarsal (HP:0001783) | 1.71021101 |
| 153 | Emphysema (HP:0002097) | 1.70423884 |
| 154 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.70116702 |
| 155 | Gastrointestinal carcinoma (HP:0002672) | 1.70116702 |
| 156 | Renal duplication (HP:0000075) | 1.70101089 |
| 157 | Flattened epiphyses (HP:0003071) | 1.69435494 |
| 158 | Long eyelashes (HP:0000527) | 1.68760767 |
| 159 | Gastrointestinal stroma tumor (HP:0100723) | 1.67190386 |
| 160 | Periodontitis (HP:0000704) | 1.66879147 |
| 161 | Striae distensae (HP:0001065) | 1.66496086 |
| 162 | Limited elbow extension (HP:0001377) | 1.64925084 |
| 163 | Cutis marmorata (HP:0000965) | 1.64808777 |
| 164 | Glomerulonephritis (HP:0000099) | 1.64750484 |
| 165 | Elfin facies (HP:0004428) | 1.62671506 |
| 166 | Vertebral clefting (HP:0008428) | 1.62143720 |
| 167 | Ankle contracture (HP:0006466) | 1.59580557 |
| 168 | Eczematoid dermatitis (HP:0000976) | 1.58888270 |
| 169 | Back pain (HP:0003418) | 1.58643016 |
| 170 | Mitral regurgitation (HP:0001653) | 1.57353250 |
| 171 | Nephritis (HP:0000123) | 1.55965062 |
| 172 | Renovascular hypertension (HP:0100817) | 1.55159017 |
| 173 | Abnormality of the gastric mucosa (HP:0004295) | 1.54197498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 5.14851016 |
| 2 | PRPF4B | 3.89140548 |
| 3 | RIPK4 | 3.71339037 |
| 4 | EEF2K | 2.76393978 |
| 5 | TRIB3 | 2.66217522 |
| 6 | TGFBR2 | 2.53391560 |
| 7 | PKN2 | 2.42366917 |
| 8 | ERN1 | 2.31122990 |
| 9 | SIK1 | 2.20716075 |
| 10 | CDK12 | 2.17942670 |
| 11 | IRAK4 | 2.11870705 |
| 12 | PTK6 | 2.11647430 |
| 13 | FGFR2 | 1.98619013 |
| 14 | LATS1 | 1.93752910 |
| 15 | MAP3K13 | 1.93405913 |
| 16 | STK10 | 1.90550025 |
| 17 | GRK6 | 1.84713412 |
| 18 | TYK2 | 1.82694270 |
| 19 | EPHB1 | 1.82491814 |
| 20 | CSF1R | 1.79184263 |
| 21 | SIK3 | 1.70956910 |
| 22 | IKBKE | 1.66048733 |
| 23 | LRRK2 | 1.65955419 |
| 24 | MAP4K1 | 1.64708615 |
| 25 | STK4 | 1.59725915 |
| 26 | SMG1 | 1.57368118 |
| 27 | TLK1 | 1.49543730 |
| 28 | FES | 1.44591112 |
| 29 | KIT | 1.42175137 |
| 30 | MATK | 1.34982520 |
| 31 | STK3 | 1.33824520 |
| 32 | RPS6KB2 | 1.33287268 |
| 33 | FRK | 1.33109726 |
| 34 | PAK4 | 1.32709685 |
| 35 | FGFR4 | 1.32515993 |
| 36 | CAMK1D | 1.32455886 |
| 37 | IRAK3 | 1.32261775 |
| 38 | FLT3 | 1.30768998 |
| 39 | FGR | 1.29192504 |
| 40 | MAP3K14 | 1.27677081 |
| 41 | PASK | 1.24780836 |
| 42 | CDC42BPA | 1.23139091 |
| 43 | ICK | 1.19300859 |
| 44 | CDK9 | 1.16583000 |
| 45 | CLK1 | 1.15387639 |
| 46 | CDK6 | 1.14600009 |
| 47 | TTN | 1.14013129 |
| 48 | FGFR3 | 1.10797035 |
| 49 | PDGFRB | 1.10655402 |
| 50 | MAP3K1 | 1.10439411 |
| 51 | ZAP70 | 1.08559038 |
| 52 | TNK2 | 1.08421959 |
| 53 | PDGFRA | 1.08209271 |
| 54 | MAP3K8 | 1.05757995 |
| 55 | MARK2 | 1.05142340 |
| 56 | CSK | 1.04614161 |
| 57 | MARK3 | 1.03919026 |
| 58 | CHUK | 1.03226020 |
| 59 | NME2 | 0.98506872 |
| 60 | MST4 | 0.98257529 |
| 61 | BRD4 | 0.96643988 |
| 62 | JAK1 | 0.96259921 |
| 63 | RIPK1 | 0.95348539 |
| 64 | BTK | 0.94788574 |
| 65 | TBK1 | 0.94160608 |
| 66 | DDR2 | 0.93217625 |
| 67 | IRAK2 | 0.91232879 |
| 68 | IRAK1 | 0.89897736 |
| 69 | IKBKB | 0.89846628 |
| 70 | PIM1 | 0.89379879 |
| 71 | TRPM7 | 0.89271954 |
| 72 | LMTK2 | 0.87441559 |
| 73 | EPHA3 | 0.86817876 |
| 74 | DYRK1B | 0.86638490 |
| 75 | ITK | 0.84354342 |
| 76 | JAK3 | 0.84121729 |
| 77 | CAMK1G | 0.83792819 |
| 78 | MAP2K2 | 0.83719437 |
| 79 | EPHA2 | 0.83443512 |
| 80 | CDK4 | 0.81882222 |
| 81 | MTOR | 0.81726679 |
| 82 | BMPR2 | 0.81554307 |
| 83 | TAOK1 | 0.81492717 |
| 84 | PRKD2 | 0.81466137 |
| 85 | MELK | 0.81228645 |
| 86 | NEK2 | 0.78918884 |
| 87 | TXK | 0.78619381 |
| 88 | MAP3K3 | 0.77474918 |
| 89 | RPS6KA4 | 0.74764438 |
| 90 | SGK3 | 0.74335562 |
| 91 | PDK1 | 0.73016650 |
| 92 | NLK | 0.71735477 |
| 93 | PDPK1 | 0.71007781 |
| 94 | MAP3K11 | 0.70490717 |
| 95 | WNK1 | 0.69942497 |
| 96 | STK24 | 0.66449916 |
| 97 | BMX | 0.66369771 |
| 98 | TAOK2 | 0.65163437 |
| 99 | HCK | 0.64292750 |
| 100 | JAK2 | 0.62932597 |
| 101 | RPS6KC1 | 0.62628712 |
| 102 | RPS6KL1 | 0.62628712 |
| 103 | SYK | 0.61648539 |
| 104 | MAPK7 | 0.61473570 |
| 105 | PRKD1 | 0.61106325 |
| 106 | CSNK1A1L | 0.60896144 |
| 107 | MAP3K7 | 0.59904290 |
| 108 | KSR2 | 0.58370573 |
| 109 | MAP2K3 | 0.57864869 |
| 110 | MAPK12 | 0.57853626 |
| 111 | TEC | 0.57517135 |
| 112 | SCYL2 | 0.56494176 |
| 113 | PAK2 | 0.56224914 |
| 114 | MAPK15 | 0.55613990 |
| 115 | SGK2 | 0.53893324 |
| 116 | INSR | 0.53729298 |
| 117 | PRKAA2 | 0.52632133 |
| 118 | NEK9 | 0.52253191 |
| 119 | BLK | 0.51314883 |
| 120 | LCK | 0.51286101 |
| 121 | PIK3CG | 0.50787513 |
| 122 | HIPK2 | 0.48842251 |
| 123 | TGFBR1 | 0.48301707 |
| 124 | MET | 0.47207587 |
| 125 | RPS6KA2 | 0.46816912 |
| 126 | GSK3A | 0.46332616 |
| 127 | EGFR | 0.45895905 |
| 128 | RPS6KA6 | 0.45549892 |
| 129 | DYRK3 | 0.44618597 |
| 130 | CDK19 | 0.43771130 |
| 131 | RET | 0.42927640 |
| 132 | TESK2 | 0.42109947 |
| 133 | PRKCQ | 0.42040164 |
| 134 | PKN1 | 0.41048030 |
| 135 | MAPKAPK2 | 0.40965529 |
| 136 | CSNK1D | 0.40040100 |
| 137 | MAPK11 | 0.39609419 |
| 138 | STK39 | 0.39217253 |
| 139 | TYRO3 | 0.37826615 |
| 140 | EPHB2 | 0.37428369 |
| 141 | CSNK1G1 | 0.36968481 |
| 142 | LYN | 0.36246357 |
| 143 | SIK2 | 0.35418958 |
| 144 | YES1 | 0.35118312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 2.87404252 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.72469035 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.60473726 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.58759976 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.56020764 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.51983883 |
| 7 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.25632164 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.07951665 |
| 9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.07895050 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90998183 |
| 11 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.74509573 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74371683 |
| 13 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.68986008 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67760959 |
| 15 | Adherens junction_Homo sapiens_hsa04520 | 1.66283706 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63768467 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62528600 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58036351 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56517069 |
| 20 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.50498439 |
| 21 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.41579628 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.39740906 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38167081 |
| 24 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.36229161 |
| 25 | Lysine degradation_Homo sapiens_hsa00310 | 1.35243550 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33063550 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27217692 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25848319 |
| 29 | Prostate cancer_Homo sapiens_hsa05215 | 1.24808004 |
| 30 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.23432094 |
| 31 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.23238579 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.19667397 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18792042 |
| 34 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.17445293 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.14920642 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13808299 |
| 37 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.12977319 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09399956 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 1.08488535 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.08099644 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07926357 |
| 42 | HTLV-I infection_Homo sapiens_hsa05166 | 1.07625831 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06217993 |
| 44 | Colorectal cancer_Homo sapiens_hsa05210 | 1.06141935 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 1.06013421 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03448195 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02257063 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00526779 |
| 49 | Measles_Homo sapiens_hsa05162 | 0.99358768 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98608211 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98228009 |
| 52 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95945116 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94870213 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.94673008 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.94433233 |
| 56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94158854 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93376463 |
| 58 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.92939900 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92040210 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91434782 |
| 61 | Pathways in cancer_Homo sapiens_hsa05200 | 0.90038322 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.88871683 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88769114 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86873653 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86670222 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.85394953 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.84045873 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82562674 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81500071 |
| 70 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80906297 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.79621300 |
| 72 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.79473355 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.74484129 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.73347221 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.72994359 |
| 76 | Alcoholism_Homo sapiens_hsa05034 | 0.72475238 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 0.72294029 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72177762 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71987680 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71848924 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.70921124 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.69627252 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.68307806 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68299677 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67190346 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65298105 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65083532 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64566664 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64173615 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63971314 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63441114 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62563751 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62482612 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61993108 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61455543 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.61330876 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61029246 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.60754892 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.60234629 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59887727 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58754359 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.57918737 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57047496 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56924895 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56091916 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55520911 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.54755928 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53688738 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53111578 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52665570 |
| 111 | Malaria_Homo sapiens_hsa05144 | 0.51736109 |
| 112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50539145 |
| 113 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50177273 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50058956 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49767030 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48105561 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47542845 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47539009 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46832537 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46446005 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46150604 |
| 122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46078607 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45911363 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45821961 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43433148 |
| 126 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43338314 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41197701 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38463841 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38460122 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36607713 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31329810 |
| 132 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29555919 |

